PT - JOURNAL ARTICLE AU - Xianyu Qin AU - Ping Li AU - Hui-Qi Qu AU - Yichuan Liu AU - Yu Xia AU - Shaoxian Chen AU - Yongchao Yang AU - Shufang Huang AU - Pengju Wen AU - Xianwu Zhou AU - Xiaofeng Li AU - Yonghua Wang AU - Lifeng Tian AU - Hakon Hakonarson AU - Yueheng Wu AU - Jian Zhuang TI - <em>FLNC</em> and <em>MYLK2</em> gene mutations in a Chinese family with different phenotypes of cardiomyopathy AID - 10.1101/2020.05.10.20097519 DP - 2020 Jan 01 TA - medRxiv PG - 2020.05.10.20097519 4099 - http://medrxiv.org/content/early/2020/05/18/2020.05.10.20097519.short 4100 - http://medrxiv.org/content/early/2020/05/18/2020.05.10.20097519.full AB - Background Mutations in the sarcomeric protein filamin C (FLNC) gene have been linked to hypertrophic cardiomyopathy (HCM), in which they increase the risk of ventricular arrhythmia and sudden death. In this study, we identified a novel missense mutation of FLNC in a Chinese family with HCM and interestingly a second novel truncating mutation of MYLK2 in one family member with different phenotype.Methods We performed whole-exome sequencing in a Chinese family with HCM of unknown cause. To validate the function of a novel mutation of FLNC, we introduced the mutant and wild-type gene into AC16 cells (human cardiomyocytes), and used western blotting to analyze the expression of FLNC in subcellular fractions, and confocal microscope to observe the subcellular distribution of the protein.Results We identified a novel missense single nucleotide variant (FLNC c.G5935A [p.A1979T]) in the family, which segregates with the disease. FLNC expression levels were equivalent in both wild type and p.A1979T cardiomyocytes. However, expression of the mutant protein resulted in cytoplasmic protein aggregations, in contrast to wild type FLNC, which was distributed in the cytoplasm and did not form aggregates. Unexpectely, a second truncating mutation, NM_033118:exon8:c.G1138T:p.E380X of the MYLK2 gene, was identified in the mother of the proband with dilated cardiomyopathy, but absent in other subjects.Conclusion We identified the FLNC A1979T mutation as a novel pathogenic variant associated with HCM in a Chinese family, as well as a second causal mutation in a family member with a distinct phenotype. The possibility of more than one causal mutations in cardiomyopathy warrants clinical attention, especially for patients with atypical clinical features.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe research reported in this publication was supported by the Guangdong Provincial Science and Technology Planning Project, Grant/Award, Number: 2017A070701013, 2017B090904034, 2017B030314109. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Department of Science and Technology of Guangdong Province.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe dataset generated for this manuscript is the whole exome sequencing data and not publicly available by the national laws of China.